...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Trial
1
Dec 10, 2019 03:57PM

You didn't miss anything. As far as I know, the Zenith mCRPC trial results haven't been announced yet.

BDAZ

3
Feb 09, 2020 10:02AM
3
Feb 09, 2020 11:00AM
5
Feb 13, 2020 02:57PM
Share
New Message
Please login to post a reply